Dr. Reddy's Laboratories shares edge down in weak market
Updated
Updated · MarketWatch · May 7
Dr. Reddy's Laboratories shares edge down in weak market
11 articles · Updated · MarketWatch · May 7
The stock fell 0.28% to 1,306.80 rupees on Thursday as the BSE Sensex slipped 0.15% to 77,844.52.
Dr. Reddy's closed 5.16% below its 52-week high of 1,377.95 rupees reached on June 12.
Among peers, Lupin rose 0.70%, Zydus Lifesciences gained 0.16% and Wockhardt dropped 4.62%, while Dr. Reddy's trading volume of 38,933 stayed well below its 50-day average of 94,400.
As a key patent expires, will Dr. Reddy's ignite a price war in India's weight-loss drug market?
With analysts deeply divided, what should investors watch for in the May 12th earnings report?